Richard L. Wynn, PhD, is professor emeritus of pharmacology in the Department of Neural and Pain Sciences at the University of Maryland School of Dentistry.

He is a nationally recognized speaker, author, columnist, and consultant on dental drug therapeutics and drug information for the dental professional. He is the lead author of the most recognized chairside dental drug reference book, Drug Information Handbook for Dentistry, now in its 29th edition.

Dr. Wynn keeps the dental profession informed about current issues relative to drugs in dentistry, including new therapeutic agents, new drug interactions, and newly reported adverse reactions in dental patients. He researches the literature daily for new reports of interest to the profession.  

In the first part of Program 5, participants will explore the detailed pharmacological profile of Triazolam, including its sedation mechanisms and metabolism. Emphasis will be placed on understanding drug interactions with CYP 3A4 inhibitors and inducers, as well as the challenges associated with the titration of sedative drugs.

Upon completing Program 5, Part 1, participants will be able to:

• Describe the pharmacology information items 1 through 11 on slide 4.
• List the mechanism of sedation by triazolam.
• Explain how triazolam is metabolized.
• Define with examples the drug interactions with CYP 3A4 inhibitors and inducers.
• Describe the challenges associated with the titration of a sedative drug.
• List the adverse reactions associated with triazolam at 0.125 mg and 0.25 mg doses.

Upon completion of the online course, participants are required to pass an online post-course assessment with a minimum grade of 75%.

Once the online course has been accessed, no refunds will be provided.

Cancellation and Refund Policies